Biliary Stents Market Forecast to Reach US$ 220.6 Million by 2032, Driven by Rising Biliary Disease Incidence and Advances in Stent Technology

The global biliary stents market, valued at approximately US$ 148.15 million in 2024, is projected to grow to nearly US$ 220.56 million by 2032, fueled by increasing incidence of biliary tract disorders, gallstones and bile duct cancers, and growing adoption of minimally invasive endoscopic procedures using advanced stent designs. 

To delve deeper into this research, kindly explore the following link: https://www.maximizemarketresearch.com/request-sample/30076/ 

Market Growth Drivers & Opportunity

A leading driver for the biliary stents market is the rising global burden of biliary diseases — including gallstones, bile duct strictures, cholangiocarcinoma and other hepatobiliary disorders — which frequently lead to duct blockage and require intervention for restoring bile flow. As the prevalence of these conditions increases worldwide, so too does the demand for effective biliary decompression and drainage solutions. 

Equally important is the growing preference for minimally invasive procedures, particularly endoscopic retrograde cholangiopancreatography (ERCP), as first-line therapy for biliary obstructions. These procedures minimize patient discomfort, shorten recovery times, and reduce hospital stays compared to open surgery, making stent implantation the standard of care in many clinical settings. 

Technological advancements in stent materials and design are further accelerating market growth. The transition from basic plastic stents to self-expanding metal stents (SEMS) — including covered, drug-eluting, and increasingly biodegradable variants — offers longer patency, reduced need for repeat interventions, and improved patient outcomes. Drug-eluting coatings, anti-migration designs, and improved flexibility enhance safety and effectiveness, broadening the use of biliary stents for both benign and malignant obstructions. 

Demographic trends also favor market expansion: as global populations age, the incidence of gallstones, strictures, and biliary cancers tends to increase, driving demand for stent-based therapies. Moreover, rising healthcare expenditure, improved access to endoscopy and interventional services in emerging economies, and heightened awareness among patients and clinicians about the benefits of early intervention and palliative care all provide fertile ground for market growth. 

To explore further details about this research, please go to: https://www.maximizemarketresearch.com/request-sample/30076/ 

Segmentation Analysis

The report segments the biliary stents market by Product Type, Application, and End-User. 

Under Product Type, biliary stents are categorized as metal (self-expanding metal stents, SEMS), plastic, and polymer-based stents. In 2024, the metal stent segment dominated the market by value, benefiting from superior patency rates, durability, and reduced need for replacements compared to plastic or polymer options. SEMS — particularly covered or drug-eluting versions — are increasingly preferred for malignant obstructions or long-term management, while plastic stents are still used in temporary or benign conditions where cost and short-term intervention suffice. 

The Application segment covers treatment of gallstones, benign biliary strictures, biliopancreatic leakages, pancreatic cancer, and other biliary tract disorders. Among these, gallstones currently represent the largest share, reflecting the high incidence of gallstone-related complications that often obstruct bile flow. As stent technology improves, usage is expanding across benign and malignant strictures, cancers, and leakage cases — especially where minimally invasive stenting presents a safer, more efficient alternative to traditional surgery. 

When viewed by End-User, hospitals remain the primary adopters of biliary stents, owing to their advanced diagnostic and interventional infrastructure, high patient throughput, and availability of ERCP and endoscopic services. Increasingly, ambulatory surgical centers and specialty clinics are also adopting stenting procedures, particularly in regions where outpatient care and short-stay interventions are prioritized to reduce costs and improve accessibility. I

Regional Analysis: North America, Europe & APAC

In North America, the biliary stents market leads globally, driven by well-established healthcare infrastructure, high awareness of biliary diseases, and widespread adoption of ERCP and other interventional procedures. The prevalence of bile duct cancers and gallstones, coupled with favorable reimbursement policies and advanced endoscopic facilities, contribute to strong demand for both metal and plastic stents. 

In Europe, demand remains stable and is supported by a growing elderly population and robust healthcare systems. Countries with high rates of gallbladder and biliary diseases, along with strong endoscopy capabilities and public health initiatives, continue to adopt biliary stents for both benign and malignant conditions. Additionally, awareness of palliative care and minimally invasive interventions is fueling growth of advanced stent designs across European markets. 

The Asia-Pacific (APAC) region is emerging as the fastest-growing market region worldwide. Rapidly expanding healthcare infrastructure, rising incidence of biliary disorders, increasing accessibility to endoscopic procedures, and growing medical tourism are key growth enablers. Countries such as China, Japan, India and South Korea are witnessing increased stent adoption, particularly as advanced metal and coated stents become more affordable and hospitals upgrade their interventional services. 

Want a comprehensive Market analysis? Check out the summary of the research report: https://www.maximizemarketresearch.com/market-report/biliary-stents-market/30076/ 

Conclusion

With the rising global prevalence of gallstones, bile duct strictures, biliary cancers, and other hepatobiliary disorders — combined with growing preference for minimally invasive, endoscopic treatments — the biliary stents market is poised for robust expansion through 2032. Advances in stent materials and designs, especially the growing use of metal, drug-eluting, and biodegradable stents, promise better patient outcomes and reduced need for repeat interventions. As hospitals, ambulatory centers, and specialty clinics across North America, Europe, and APAC adopt these solutions at increasing rates, the future of biliary stents appears promising, offering important clinical benefits and significant opportunities for industry stakeholders.

About Us:

Maximize Market Research is one of the fastest-growing Market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

Contact Us:

MAXIMIZE Market RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
[email protected]